


Novelogics Biotechnology Revenue
Biotechnology Research • Coquitlam, British Columbia, Canada • 1-10 Employees
Novelogics Biotechnology revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Novelogics Biotechnology
Elaine Allison
Co-Founder, CEO
Company overview
| Headquarters | Vancouver, BC V3C 0A3, CA |
| Website | |
| SIC | 873 |
| Founded | 2013 |
| Employees | 1-10 |
| Socials |
About Novelogics Biotechnology
Novelogics is a privately-held, preclinical stage biotech company developing a novel monoclonal antibody immunotherapy drug for the treatment of cancer. The company is based in Vancouver, Canada. Our antibody drug interacts with target proteins known to be immune suppressive and which function to reduce the ability of the immune system to detect and destroy unwanted cancer cells. This drug target is found in multiple deadly cancer types including solid tumors, blood cancers and in other diseases, thereby implying that the potential market for our drug is large. Novelogics’ innovative therapeutic approach restores immune responses against cancer cells and is expected to treat cancer patients in a safer fashion while maintaining their quality of life.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Novelogics Biotechnology has 1 employees across 1 departments.
Departments
Number of employees
Novelogics Biotechnology Tech Stack
Discover the technologies and tools that power Novelogics Biotechnology's digital infrastructure, from frameworks to analytics platforms.
Hosting
Frequently asked questions
4.8
40,000 users



